RaySearch to present latest innovations in RayStation, RayCare and RayIntelligence at ISOP and NPC (NAPT)
RaySearch Laboratories AB (publ) will present the latest software innovations at IBA’s International Symposium on Proton Therapy (ISOP) in Boston, Massachusetts, April 5, and at the National Proton Conference (NPC) run by the National Association on Proton Therapy (NAPT) in Boston, April 6-9. Visit us at RaySearch’s table at ISOP and booth at NPC.
The focus during both ISOP and NPC will be on support for proton arcs and robust optimization based on linear energy transfer (LET) and adaptive therapy. Further, new features in RayStation®* 2023B related to proton therapy will be highlighted. Ongoing research and development around ConformalFLASH®**, spatial fraction therapy and application of variable RBE will be briefly outlined.
Marc Mlyn, President of RaySearch Americas, and David McPhail, VP of Sales for RaySearch Americas, will be present at the meetings and look forward to meeting existing and future clinical partners.
Presentations – Friday April 5 at 12:35pm (ISOP) and Sunday April 7 at 4:00pm (NPC)
Title: Proton Therapy Planning – Pioneering the Past, Envisioning the Future
Speaker: Erik Traneus, Senior Researcher, RaySearch Laboratories AB, Stockholm, Sweden
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 1,000 centers in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
About RayCare
The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.
About RayIntelligence
Data-driven oncology represents a new era in healthcare. RayIntelligence® is an innovative cloud-based oncology analytics system that gives meaning to data, empowering cancer centers to reach new levels of personalized care through insights based on clinical data.
* Subject to regulatory clearance in some markets.
** ConformalFLASH® is a registered brand of the IBA Proton Flash therapy solution currently in research and development phase.
Tags:
